Early clinical results support Da Vinci FS laser

Article

Swiss firm, Ziemer Ophthalmic Systems took advantage of the ESCRS congress to reveal its femtosecond laser Da Vinci to the ophthalmic community.

Swiss firm, Ziemer Ophthalmic Systems took advantage of the ESCRS congress to reveal its femtosecond laser Da Vinci to the ophthalmic community.

During wet lab demonstrations, ophthalmologists took the opportunity to sample the Da Vinci systems, the first series of which are making their way off the assembly line and into more extensive clinical testing.

Following an initial series of regular clinical applications, performed in collaboration with refractive surgeons in Switzerland, Germany and the UK, LASIK flaps were created in the corneas of LASIK patients, followed by standard excimer laser ablation.

According to the surgeons, the Femto-LASIK procedure was uneventful and yielded satisfactory outcomes with target refraction achieved and no complications reported. At two-week follow-up, there were no apparent signs of laser-induced complications.

Ophthalmology Times Europe reporting from the XXIV Congress of the ESCRS, London, 9-13 September, 2006.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.